Results 71 to 80 of about 944 (117)

SINEUP-Mediated Overexpression of Endogenous α-Amylase as a Therapeutic Approach in Lafora Disease. [PDF]

open access: yesGenes (Basel)
Allegri L   +8 more
europepmc   +1 more source

Trehalose Treatment in Zebrafish Model of Lafora Disease. [PDF]

open access: yesInt J Mol Sci, 2022
Della Vecchia S   +11 more
europepmc   +1 more source

Identification of Plasma Growth Factors and Cytokines as Diagnostic Biomarkers for the Lafora Form of Progressive Myoclonus Epilepsy. [PDF]

open access: yesInt J Mol Sci
Moreno-Estellés M   +9 more
europepmc   +1 more source

Gene therapy for Lafora disease in the Epm2a<sup>-/-</sup> mouse model. [PDF]

open access: yesMol Ther
Zafra-Puerta L   +10 more
europepmc   +1 more source

Focused ultrasound widely broadens AAV-delivered Cas9 distribution and activity. [PDF]

open access: yesGene Ther
Gumusgoz E   +13 more
europepmc   +1 more source

Drug-Resistant Early-Onset Progressive Myoclonic Epilepsy Revealing Lafora Disease: A Case Report. [PDF]

open access: yesCureus
Pejanovic-Skobic N   +5 more
europepmc   +1 more source

An astrocytic cellular model of Lafora disease to study polyglucosan accumulation and inflammation. [PDF]

open access: yesDis Model Mech
Moreno-Estellés M   +7 more
europepmc   +1 more source

Glycogenin-1 deficiency: a case report and review of the literature. [PDF]

open access: yesFront Genet
Molitierno N   +12 more
europepmc   +1 more source

Effect of intracerebroventricular administration of alglucosidase alfa in two mouse models of Lafora disease: Relevance for clinical practice. [PDF]

open access: yesEpilepsy Res
Zafra-Puerta L   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy